1 Berkhemer OA, Fransen PS, Beumer D, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372:11-20.

 2 Goyal M, Demchuk AM, Menon BK, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372:1019-1030.

 3 Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372:1009-1018.

 4 Saver JL, Goyal M, Bonafe A, et al. SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015-04-17, [Epub ahead of print].

 5 Jovin TG, Chamorro A, Cobo E, et al. REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015-04-17, [Epub ahead of print].

 6 European Stroke Organisation (ESO). Consensus statement on mechanical thrombectomy in acute ischemic stroke[EB]. (2014-11-16)[2015-05-17], http://2014.strokeupdate.org/sites/default/files/Consensus_thrombectomy_ESO_Karolinska_ESMINT_ESNR_final.pdf.

 7 Jayaraman MV, Hussain MS, Abruzzo T, et al. Standards and Guidelines Committee of the Society of NeuroInterventional Surgery (SNIS). Embolectomy for stroke with emergent large vessel occlusion (ELVO):report of the Standards and Guidelines Committee of the Society ofNeuroInterventional Surgery[J]. J Neurointerv Surg, 2015, 7:316-321.

 8 Broderick JP, Palesch YY, Demchuk AM, et al. Interventional Management of Stroke (IMS) Ⅲ Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368:893-903.

 9 Ciccone A, Valvassori L, Nichelatti M, et al. SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368:904-913.

10 Kidwell CS, Jahan R, Gornbein J, et al. MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368:914-923.

11 Mas JL, Chatellier G, Beyssen B, et al. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis[J]. N Engl J Med, 2006, 355:1660-1671.

12 Mas JL, Trinquart L, Leys D, et al. EVA-3S investigators. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial:results up to 4 years from a randomised, multicentre trial[J]. Lancet Neurol, 2008, 7:885-892.

13 Mas JL, Arquizan C, Calvet D, et al. EVA-3S investigators. Long-term follow-up study of endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis trial[J]. Stroke, 2014, 45:2750-2756.

14 Chimowitz MI, Lynn MJ, Derdeyn CP, et al. SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J]. N Engl J Med, 2011, 365:993-1003.

15 Zaidat OO, Fitzsimmons BF, Woodward BK, et al. VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis:the VISSIT randomized clinical trial[J]. JAMA, 2015, 313:1240-1248.

16 Miao Z, Song LL, Liebeskind DS, et al. Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis:a prospective cohort study after SAMMPRIS[J]. J NeuroIntervent Surg, 2014, 7:331-335.